Pharmacokinetic comparison between a fixed-dose combination of fimasartan/amlodipine/hydrochlorothiazide 60/10/25 mg and a corresponding loose combination of fimasartan/amlodipine 60/25 mg and hydrochlorothiazide 25 mg in healthy subjects

For the treatment of hypertension, fixed-dose combinations (FDCs) of antihypertensive drugs can provide complementary benefits from improved compliance and cost-effectiveness compared with loose combinations of corresponding drugs. A new FDC of fimasartan/amlodipine/hydrochlorothiazide 60/10/25 mg i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Jihyun, Lee, Soyoung, Oh, Jaeseong, Lee, SeungHwan, Jang, In-Jin, Lee, Donghwan, Yu, Kyung-Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Clinical Pharmacology and Therapeutics 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020363/
https://www.ncbi.nlm.nih.gov/pubmed/33855001
http://dx.doi.org/10.12793/tcp.2021.29.e5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020363/
https://www.ncbi.nlm.nih.gov/pubmed/33855001
http://dx.doi.org/10.12793/tcp.2021.29.e5

Ejemplares similares